Using risk assessment to evaluate adverse selection under capitated contracts
Related Experiment Video
Updated: Oct 23, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
1PM Squared, Inc., San Francisco, CA, USA.
Abstract:
Most provider organizations rely on health plan or market-based information about capitation rates, per member per month costs, and utilization trends to benchmark their performance. However, these statistics can be misleading because of differences in enrollee mix and contracting terms across provider organizations. This article describes the limitations of health plan contract provisions in protecting against adverse selection. It describes various actuarial and statistical data sources for evaluation of adverse selection. The article then presents various approaches to risk adjustment on population basis and their use in quantifying adverse selection for health plan contract negotiations.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Kaplan-Meier Approach
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Hazard Rate
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...